PUMA [10D4G7] Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-PUMA [10D4G7] antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPUMA [10D4G7]
Clone[10D4G7]
Host SpeciesMouse
Reactive Specieshuman, rat
IsotypeIgG1
Formatimmunoaffinity purified
Size0.1 mg
Concentration1 mg/mL
ApplicationsELISA (EIA), Western Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionPUMA Monoclonal Antibody: Apoptosis is related to many diseases and development. The p53 tumor-suppressor protein induces apoptosis through transcriptional activation of several genes. A novel p53 inducible pro-apoptotic gene was identified recently and designated PUMA (for p53 upregulated modulator of apoptosis) and bbc3 (for Bcl-2 binding component 3) in human and mouse. PUMA/bbc3 is one of the pro-apoptotic Bcl-2 family members including Bax and Noxa, which are also transcriptional targets of p53. The PUMA gene encodes two BH3 domain-containing proteins termed PUMAα and PUMAβ. PUMA proteins bind Bcl-2, localize to the mitochondria, and induce cytochrome c release and apoptosis in response to p53. PUMA may be a direct mediator o
ImmunogenImmunogen: Recombinant protein corresponding to amino acids 76 - 170 of human PUMA-alpha. Buffer: PUMA Monoclonal Antibody is supplied in PBS containing 0.02% sodium azide.
Other Names[PUMA [10D4G7] : JFY1; PUMA; JFY-1; BCL2 binding component 3], [BBC3; BBC3; JFY1; PUMA; JFY-1; PUMA]
Gene, Accession #[BBC3], Gene ID: 27113, NCBI: Q9BXH1.1, UniProt: Q9BXH1
Catalog #MBS150004
Price$375
Order / More InfoPUMA [10D4G7] Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.